Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 st January 31 st March 2015

Size: px
Start display at page:

Download "Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 st January 31 st March 2015"

Transcription

1 Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 st January 31 st March The cumulative cases report since December 2010 and cases report during January to March 2015 During 1 st January to 31 st March 2015, there were 53 cases reported to the severe pneumonia database from 12 provinces including of 4 deaths. Twenty cases were reported from Surat Thani, followed by six cases each from Phra Nakhon Si Ayutthaya, Saraburi and Chiang Mai, four cases from Kamphaeng Phet, three cases each from Prachuap Khiri Khan and Chanthaburi, one case each from Kanchanaburi, Phitsanulok, Nakhon Si Thammarat, Phetchaburi and Sukhothai (Figure 1). Of 53 cases, 30 were male and 23 were female. Male to female ratio was 1.30:1. Median age was 4.5 years old (2 months to 88 years). Twenty-nine cases were children age 2 months to 5 years (54.72%) (Figure 2). Since 1 st December 2010 to 31 st March 2015 the Bureau of Epidemiology received 824 cases reported to the severe pneumonia database from 16 provinces including 159 deaths (9 cases autopsy/necropsy were done). The highest number were reported from Surat Thani (275), followed by Chiang Mai (143), Phra Nakhon Si Ayutthaya (72), Kamphaeng Phet (54), Prachuap Khiri Khan (52) and Chanthaburi (47). Of 824 cases, 496 were male and 328 were female. Male to female ratio was 1.51:1. Median age was 2 years old (2 months to 97 years). Five hundred and nine cases were children age 2 months to 5 years (61.77%). 2. Laboratory results All specimens were sent to the National Institute of Health for laboratory testing. Since 1 st December 2010 to 31 st March 2015, a total of 824 specimens were analyzed by Real time RT-PCR and conventional method, 484 specimens (58.74%) were identified as positive. During 1 st January to 31 st March 2015, the pathogens were founded and identified in 36 cases from 53 cases (Table 1). From 36 positive lab results, we found 4 cases with viral infection, 18 cases with bacterial infection and 14 cases with co-infection.

2 Severe / Fatal pneumonia cases Surat Thani Chiang Mai Phra Nakhon Prachuap Khiri Chanthaburi Kamphaeng Kanchanaburi Sukhothai Phitsanulok Saraburi Chachoengsao Si Sa Ket Chiang Rai Phetchaburi Uttaradit Nakhon Si Quarterly cases/deaths Case (1 Jan - 31 Mar 2015) Case (1 Dec Mar 2015) Provinces Figure 1 Total number of severe and fatal pneumonia cases reported to the severe pneumonia database by provinces Severe pneumonia (1 Jan - 31 Mar 2015) Fatal pneumonia (1 Jan - 31 Mar 2015) 0 2 mo. - 5 yrs yrs yrs yrs. > 60 yrs. Age Figure 2 Total number of severe/fatal pneumonia cases reported to the severe pneumonia database by age group.

3 Table 1 Laboratory results of reported severe and fatal pneumonia cases to the severe pneumonia database. (Tested by NIH) Pathogen Severe pneumonia 1 Jan 31 Mar Dec Mar 2014 Viral infection (from tracheal secretion) Adenovirus 1 28/1 Human metapneumovirus 0/4 Influenza virus A (H1N1/2009) 1 9/6 Influenza virus A/H3 0 8/5 Influenza virus B 1 4/1 Respiratory syncytial virus 06/10 Parainfluenza virus type Parainfluenza virus type 2 0 4/1 Parainfluenza virus type 3 0/3 Mixed viral infection (from tracheal secretion) Respiratory syncytial virus and Human metapneumovirus /1 Parainfluenza virus type 3 and Adenovirus 1 3/1 Parainfluenza virus type 3 and Humanmetapneumovirus Respiratory syncytial virus and Parainfluenza virus type 3 Respiratory syncytial virus and Poliovirus type 2, 3 vaccine Respiratory syncytial virus and Influenza virus A(H1N1)2009 Influenza virus A(H1N1)2009 and Adenovirus Bacterial infection (from tracheal secretion) Chlamydophila pneumoniae 2/2 Mycoplasma pneumoniae 3 21/5 3 10/2 Legionella species Streptococcus pneumoniae 0 3/2 Moraxella catarrhalis 1 9/1 Klebsiella pneumoniae 0 6/2 Pseudomonas aeruginosa Acinetobacter baumannii 0 0/3 0 3 Staphylococcus aureus 0 3/4 Burkholderia pseudomallei 0 0/2

4 Severe pneumonia Pathogen 1 Jan 3 Dec 2010 Mar Mar 2014 Acinetobacter calcoaceticus 0 0/1*** Bacterial infection (from fresh lung tissue) Staphylococcus Coagulase 0 0/1*** Chlamydophila pneumoniae 0 0/1 Acinetobacter spp. 0 0/1** Mixed bacterial infection (from tracheal secretion) Chlamydophila pneumoniae and Moraxella catarrhalis 1 4 Chlamydophila pneumoniae and Mycoplasma pneumoniae Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Klebsiella pneumoniae Mycoplasma pneumoniae and Klebsiella pneumoniae Mycoplasma pneumoniae and Moraxella catarrhalis Mycoplasma pneumoniae and Mycoplasma pneumonia, and Klebsiella pneumoniae Mycoplasma pneumoniae and Streptococcus pneumoniae 1 2 Mycoplasma pneumoniae and 2 2 Mycoplasma pneumoniae, andmoraxella catarrhalis and Klebsiella pneumoniae 1 6/12 and /1 and Streptococcus pneumoniae 0 0/1 and Burkholderia pseudomallei and Staphylococcus aureus 0 0/1, Mycoplasma pneumoniae and Haemophilus influenzae, and Moraxella catarrhalis Pseudomonas aeruginosa and Staphylococcus aureus 0 0/1 Streptococcus pneumoniae and Streptococcus pneumoniae and Moraxella catarrhalis

5 Pathogen Severe pneumonia 1 Jan 31 Mar Dec Mar 2014 Streptococcus pneumoniae, and Klebsiella pneumoniae Acinetobacter baumannii and Acinetobacter spp. Klebsiella pneumonia, Moraxella catarrhalis and Staphylococcus aureus Klebsiella pneumonia and Pseudomonas aeruginosa and Moraxella catarrhalis 0 4/1 Morganella morganii, Citrobacter freundii (Moderate), Escherichia coil (Moderate), Pseudomonas aeruginosa (Few), gamma-hemolysis Streptococci (Moderate), alpha-hemolysis Streptococci (Moderate) Moderate alpha-hemolytic Streptococci, Moderate Diphtheroid, Few Acinetobacter lwoffi 0 0/1 Mixed bacterial infection (from fresh lung tissue) Klebsiella pneumoniae and Acinetobacter lwoffi 0 0/1* Mixed bacterial infection (from fresh liver tissue) and Klebsiella pneumoniae 0 0/1* Co-infection (from tracheal secretion) Adenovirus and Acinetobacter baumannii 0 0/1 Adenovirus,, Moraxella catarrhalis and Adenovirus and Moraxella catarrhalis 1 2 Adenovirus and Mycoplasma pneumoniae Adenovirus, Streptococcus pneumoniae and Haemophilus influenzae 0 0/1 Adenovirus, Humanmetapneumovirus and Haemophilus influenzae Adenovirus and Adenovirus, Influenza virus B, Moraxella catarrhalis and Adenovirus, Parainfluenza virus type 2, Chlamydophila pneumoniae and Mycoplasma pneumonia

6 Pathogen Severe pneumonia 1 Jan 31 Mar Dec Mar 2014 Adenovirus, Chlamydophila pneumoniae and Mycoplasma pneumoniae Respiratory syncytial virus and Mycoplasma pneumoniae 0 2 Respiratory syncytial virus and Streptococcus pneumoniae 0 3 Respiratory syncytial virus and Klebsiella pneumoniae Respiratory syncytial virus and Respiratory syncytial virus and Chlamydophila pneumoniae 0 2 Respiratory syncytial virus and Moraxella catarrhalis 2 Respiratory syncytial virus and 5 Respiratory syncytial virus, and Moraxella catarrhalis Respiratory syncytial virus, and Respiratory syncytial virus, Klebsiella pneumoniae and Respiratory syncytial virus, Mycoplasma pneumoniae and Respiratory syncytial virus, Human metapneumovirus and Respiratory syncytial virus, Parainfluenza virus type 2 and Moraxella catarrhalis Respiratory syncytial virus, Parainfluenza virus type 1 and Respiratory syncytial virus, Mycoplasma pneumoniae and Streptococcus pneumoniae Respiratory syncytial virus, Haemophilus influenza and Streptococcus pneumoniae Respiratory syncytial virus, Chlamydophila pneumonia and Mycoplasma pneumoniae /1

7 Severe pneumonia Pathogen 1 Jan 3 Dec 2010 Mar Mar 2014 Influenza virus A/H3 and Acinetobacter baumannii Influenza virus A/H3 and Streptococcus pneumoniae Influenza virus A/H3 and Staphylococcus aureus /1 Influenza virus A/H3 and Klebsiella pneumoniae 0 0/1 Influenza virus A/H3 and Mycoplasma pneumoniae 1 3 Influenza virus A/H3 and Pseudomonas aeruginosa 0 0/1 Influenza virus A/H3, Chlamydophila pneumoniae, Mycoplasma pneumoniae and Streptococcus pneumoniae Influenza virus B and Pseudomonas aeruginosa Influenza virus B and 0 0/1 Influenza virus B, and Mycoplasma pneumoniae Parainfluenza virus type 3, Klebsiella pneumoniae and 0 0/1 Parainfluenza virus type 3, and Parainfluenza virus type 3 and Moraxella catarrhalis Parainfluenza virus type 3 and Mycoplasma pneumoniae 2 2 Parainfluenza virus type 3 and Humanmetapneumovirus and Humanmetapneumovirus and 0 0/1 Humanmetapneumovirus and Moraxella catarrhalis Humanmetapneumovirus and Chlamydophila pneumoniae Humanmetapneumovirus and Streptococcus pneumoniae Humanmetapneumovirus and Pseudomonas aeruginosa Humanmetapneumovirus and Mycoplasma pneumoniae Humanmetapneumovirus, Mycoplasma pneumoniae and Humanmetapneumovirus, Chlamydophila pneumoniae and Streptococcus pneumoniae Influenza virus A(H1N1) 2009 and Moraxella catarrhalis Influenza virus A(H1N1) 2009 and Mycoplasma pneumoniae 0/1 0/1 Influenza virus A(H1N1) 2009 and Acinetobacter baumannii 0 0/1

8 Severe pneumonia Pathogen 1 Jan 3 Dec 2010 Mar Mar 2014 Influenza virus A(H1N1) 2009 and Streptococcus pneumoniae /1 Influenza virus A(H1N1) 2009, Streptococcus pneumoniae and Moraxella catarrhalis Influenza virus A(H1N1)2009 and 1 2/1 Influenza virus A(H1N1)2009, Adenovirus and Acinetobacter baumannii Influenza virus A(H1N1)2009, Mycoplasma pneumoniae and Parainfluenza virus type 2, and Legionella pneumophila 0 0/1** 0/1 0/1 Parainfluenza virus type 2 and Parainfluenza virus type 1 and Chlamydophila pneumoniae Parainfluenza virus type 1 and Mycoplasma pneumoniae Parainfluenza virus type 1 and Klebsiella pneumoniae 0 0/1 Parainfluenza virus type 1 and Moraxella catarrhalis Total * Patient case1, ** Patient case2, *** Patient case3

Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 April - 30 June 2014

Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 April - 30 June 2014 Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 April - 3 June 214 1. The cumulative cases report since December 21 and cases report during April to June 214 During 1 April to 3 June

More information

Respiratory Pathogen Panel TEM-PCR Test Code:

Respiratory Pathogen Panel TEM-PCR Test Code: Respiratory Pathogen Panel TEM-PCR Test Code: 220000 Tests in this Panel Enterovirus group Human bocavirus Human coronavirus (4 types) Human metapneumovirus Influenza A - Human influenza Influenza A -

More information

Influenza A (H1N1)pdm09 in Minnesota Epidemiology

Influenza A (H1N1)pdm09 in Minnesota Epidemiology Influenza A (H1N1)pdm09 in Minnesota Epidemiology Infectious Disease Epidemiology, Prevention and Control Division PO Box 64975 St. Paul, MN 55164-0975 Number of Influenza Hospitalizations by Influenza

More information

Creating a User Defined Pneumonia-Specific Syndrome in ESSENCE. Preventive Medicine Directorate September 2016

Creating a User Defined Pneumonia-Specific Syndrome in ESSENCE. Preventive Medicine Directorate September 2016 Creating a User Defined Pneumonia-Specific Syndrome in ESSENCE Preventive Medicine Directorate September 2016 0 Pneumonia-Specific Syndrome NMCPHC retrospective analyses suggest that surveillance using

More information

Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders?

Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders? Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders? David Murdoch Department of Pathology University of Otago, Christchurch Outline Background Diagnostic challenges

More information

Potential Reimbursement CPT Codes

Potential Reimbursement CPT Codes BioFire FilmArray Blood Culture Identification (BCID) Panel Medicare All targets (n) 87150 n x * *BioFire BCID Panel is comprised of 27 total targets. The number of targets allowed for reimbursement may

More information

Protocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel

Protocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel Protocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel Laboratory Protocols for Use with a ZeptoMetrix NATtrol Verification Panel Purpose The Clinical Laboratory

More information

Protocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel plus

Protocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel plus Protocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel plus Laboratory Protocols for Use with a ZeptoMetrix NATtrol Verification Panel Purpose The Clinical Laboratory

More information

Retrospective and Prospective Verification of the Cepheid Xpert Flu Assay

Retrospective and Prospective Verification of the Cepheid Xpert Flu Assay JCM Accepts, published online ahead of print on 20 July 2011 J. Clin. Microbiol. doi:10.1128/jcm.01162-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

Cefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010

Cefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010 Cefotaxime Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the European

More information

PAMET Continuing Education 2016

PAMET Continuing Education 2016 PAMET Continuing Education 2016 Agent of gastroenteritis Medium/method] used for routine screening/detection in stool samples Salmonella, Shigella, MacConkey, Hektoen, Bismuth sulfite,etc. Plesiomonas

More information

CDC Cooperative Agreement Influenza Surveillance Review Project Period(Sep 2004-Sep 2011)

CDC Cooperative Agreement Influenza Surveillance Review Project Period(Sep 2004-Sep 2011) CDC Cooperative Agreement Influenza Surveillance Review Project Period(Sep 2004-Sep 2011) National Institute of Health Department of Medical Sciences, Bureau of Epidemiology Department of Disease Control,

More information

INFECTIOUS DISEASE. Page 2

INFECTIOUS DISEASE. Page 2 Infectious disease Advantages OF TESTING INFECTIOUS DISEASE We are in the middle of a paradigm shift in infectious disease diagnostic testing. As we move from targeted infectious disease testing to a syndromic

More information

Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version th September 2010

Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version th September 2010 Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the

More information

RESPIRATORY WATCH Week 3 (January 14 to January 20, 2018)*

RESPIRATORY WATCH Week 3 (January 14 to January 20, 2018)* Number of positive specimens RESPIRATORY WATCH Week (January to January, )* IN SUMMARY Activity levels** Zones, & are reporting localized activity. The is no activity being reported in Zone. There have

More information

Community Acquired Pneumonia. Abdullah Alharbi, MD, FCCP

Community Acquired Pneumonia. Abdullah Alharbi, MD, FCCP Community Acquired Pneumonia Abdullah Alharbi, MD, FCCP A 68 y/ male presented to the ED with SOB and productive coughing for 2 days. Reports poor oral intake since onset due to nausea and intermittent

More information

RESPIRATORY WATCH Week 2 (January 6, 2019 to January 12, 2019 )*

RESPIRATORY WATCH Week 2 (January 6, 2019 to January 12, 2019 )* Number of positive specimens RESPIRATORY WATCH Week (January, to January, )* IN SUMMARY Activity levels** Central and Western Zones have localized activity. Northern and Eastern Zones are reporting sporadic

More information

M O L E C U L A R G E N E T I C S

M O L E C U L A R G E N E T I C S MOLECULAR GENETICS ADVANTAGES OF MOLECULAR GENETICS Molecular genetics is a dynamic and transformative area of diagnostics, leading to insights in research and treatment in many disease states that are

More information

12/12/2011. Atypical Pneumonia. Objectives. Causative Agents of Acute Pneumonia Bacteria. Causative Agents of Acute Pneumonia Other Agents

12/12/2011. Atypical Pneumonia. Objectives. Causative Agents of Acute Pneumonia Bacteria. Causative Agents of Acute Pneumonia Other Agents Objectives Atypical Pneumonia K. Sue Kehl, Ph.D., D(ABMM) Associate Professor, Pathology Medical College of Wisconsin Associate Director of Clinical Pathology & Technical Director of Microbiology, Children's

More information

Streptococci facultative anaerobe

Streptococci facultative anaerobe THE GENUS STREPTOCOCCUS The genus Streptococcus obtains Gram-positive cocci, nonmotile, nonsporeforming, arranged mostly in chains or in pairs. Most species are facultative anaerobes. Some of streptococci

More information

The cost-saving, effective diagnoses of melioidosis in Cambodia. Vanaporn Wuthiekanun Faculty of Tropical Medicine Mahidol University

The cost-saving, effective diagnoses of melioidosis in Cambodia. Vanaporn Wuthiekanun Faculty of Tropical Medicine Mahidol University Angkor hospital for Children at Siem Reap The cost-saving, effective diagnoses of melioidosis in Cambodia Vanaporn Wuthiekanun Faculty of Tropical Medicine Mahidol University Angkor Wat Ta Prohm Bayon

More information

Influenza Weekly Surveillance Bulletin

Influenza Weekly Surveillance Bulletin Influenza ly Surveillance Bulletin Northern Ireland, ( 1 January ) Summary GP consultation rates for combined flu/ FLI decreased from 1./, population (updated) in week to./, in week (4% decrease). o flu/fli

More information

Ontario Respiratory Pathogen Bulletin I

Ontario Respiratory Pathogen Bulletin I Ontario Respiratory Pathogen Bulletin I 2017-2018 SURVEILLANCE WEEK 3 (January 14, 2018 January 20, 2018) This issue of the Ontario Respiratory Pathogen Bulletin provides information on the surveillance

More information

Validation FTD Respiratory pathogens 33

Validation FTD Respiratory pathogens 33 Validation FTD Respiratory pathogens 33 32 reactions (catalog no. FTD-2P.3-32) 64 reactions (catalog no. FTD-2P.3-64) Qualitative assay for in vitro diagnostics Validated with: Applied Biosystems 7500

More information

Respiratory Multiplex Array. Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract

Respiratory Multiplex Array. Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract Rapid, simultaneous detection of 22 bacterial and viral pathogens within the upper and lower respiratory

More information

Cell counting (EtBr) Before cell-lysis. Cell-lysis by 3% SDS beads beating. After cell-lysis

Cell counting (EtBr) Before cell-lysis. Cell-lysis by 3% SDS beads beating. After cell-lysis Key words Sample Cell counting (EtBr) DNA extraction Cell-lysis by 3% SDS beads beating Before cell-lysis After cell-lysis Cell-lysis efficiency (Maintained70%) PCR PCR amplification of partial fragments

More information

Consultation on the Revision of Carbapenem Breakpoints

Consultation on the Revision of Carbapenem Breakpoints Consultation on the Revision of Carbapenem Breakpoints July 2018 Please send comments to the EUCAST Scientific Secretary at jturnidge@gmail.com by September 15. EUCAST revision of carbapenem breakpoints

More information

Table 1: Summary of Texas Influenza (Flu) and Influenza-like Illness (ILI) Activity for the Current Week Texas Surveillance Component

Table 1: Summary of Texas Influenza (Flu) and Influenza-like Illness (ILI) Activity for the Current Week Texas Surveillance Component Texas Surveillance Report 2017 2018 Season/2018 MMWR Week 03 (Jan. 14, 2018 Jan. 20, 2018) Report produced on 1/27/2018 Summary activity remains high across the state of Texas. Compared to the previous

More information

Babak Valizadeh, DCLS

Babak Valizadeh, DCLS Laboratory Diagnosis of Bacterial Infections of the Respiratory Tract Babak Valizadeh, DCLS 1391. 02. 05 2012. 04. 25 Babak_Valizadeh@hotmail.com Biological Safety Cabinet Process specimens in biological

More information

Tarrant County Influenza Surveillance Weekly Report CDC Week 10: March 04-10, 2012

Tarrant County Influenza Surveillance Weekly Report CDC Week 10: March 04-10, 2012 Tarrant County Public Health Division of Epidemiology and Health Information Tarrant County Influenza Surveillance Weekly Report CDC Week 10: March 04-10, 2012 Influenza Activity Code, County and State

More information

Syndromic Testing: The right test, the first time.

Syndromic Testing: The right test, the first time. Syndromic Testing: The right test, the first time. Don t guess. Know. Infectious disease diagnostics has evolved. BioFire s syndromic approach is making the world a healthier place. Many infectious diseases

More information

Tarrant County Influenza Surveillance Weekly Report CDC Week 02: January 08 14, 2012

Tarrant County Influenza Surveillance Weekly Report CDC Week 02: January 08 14, 2012 Tarrant County Public Health Division of Epidemiology and Health Information Tarrant County Influenza Surveillance Weekly Report CDC Week 02: January 08 14, 2012 Influenza Activity Code, County and State

More information

RSV Surveillance in the U.S.

RSV Surveillance in the U.S. RSV Surveillance in the U.S. Susan I. Gerber, MD Respiratory Virus Program Division of Viral Diseases National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention

More information

SUPPLEMENTARY MATERIAL

SUPPLEMENTARY MATERIAL SUPPLEMENTARY MATERIAL (A) Further inclusion criteria and categorisation of ICD-10 diagnostic codes Pneumonia: A310 Pulmonary mycobacterial infection A420 Pulmonary actinomycosis A481 Legionnaires' disease

More information

Evaluation of the Oxoid Xpect Legionella test kit for Detection of Legionella

Evaluation of the Oxoid Xpect Legionella test kit for Detection of Legionella JCM Accepts, published online ahead of print on 6 May 2009 J. Clin. Microbiol. doi:10.1128/jcm.00397-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance Flu Watch MMWR Week 4: January 21 to January 27, 218 All data are provisional and subject to change as more reports are received. Geographic Spread South Carolina reported widespread activity this week.

More information

Tarrant County Influenza Surveillance Weekly Report CDC Week 06: February 05 11, 2012

Tarrant County Influenza Surveillance Weekly Report CDC Week 06: February 05 11, 2012 Tarrant County Public Health Division of Epidemiology and Health Information Tarrant County Influenza Surveillance Weekly Report CDC Week 06: February 05 11, 2012 Influenza Activity Code, County and State

More information

PATHOGEN DETECTION WITH THE FILMARRAY

PATHOGEN DETECTION WITH THE FILMARRAY PATHOGEN DETECTION WITH THE FILMARRAY The System Sample-to-Answer in an Hour Single sample Multiple samples The FilmArray integrates sample preparation, amplification, detection, and analysis all into

More information

Acute lower respiratory infections

Acute lower respiratory infections 18 Acute lower respiratory infections Introduction i Key points Community-acquired pneumonia is the most frequent cause of death from infection in Europe. The majority of patients with pneumonia are treated

More information

Surveillance of Influenza in Northern Ireland

Surveillance of Influenza in Northern Ireland Surveillance of Influenza in Northern Ireland 2016 2017 Contents Summary... 1 Introduction... 3 Enhanced influenza surveillance systems... 3 In-hours Sentinel GP Practice surveillance... 3 GP Out-of-Hours

More information

Chain of Infection Agent Mode of transmission Contact (direct, indirect, droplet spread) Airborne Common-vehicle spread Host

Chain of Infection Agent Mode of transmission Contact (direct, indirect, droplet spread) Airborne Common-vehicle spread Host Goals Microbiology of Healthcare-associated Infections William A. Rutala, Ph.D., M.P.H. Director, Statewide Program for Infection Control and Epidemiology and Research Professor of Medicine, University

More information

Emerging Respiratory Infections NZ Amanda McNaughton Respiratory Physician CCDHB Wellington

Emerging Respiratory Infections NZ Amanda McNaughton Respiratory Physician CCDHB Wellington Emerging Respiratory Infections NZ 2015 Amanda McNaughton Respiratory Physician CCDHB Wellington Respiratory Infection: overview Influenza virus Clinical picture Emerging infection New Zealand Influenza

More information

BACTERIOLOGY PROGRAMME AND PLAN OF TEACHING 3 rd Semester (academic year )

BACTERIOLOGY PROGRAMME AND PLAN OF TEACHING 3 rd Semester (academic year ) BACTERIOLOGY PROGRAMME AND PLAN OF TEACHING 3 rd Semester (academic year 2012-2013) 19. 10. 2012. Introduction in microbiology, bacterial taxonomy, general bacterial prop Bacterial structures, biosynthesis

More information

Pediatric influenza-associated deaths in Arizona,

Pediatric influenza-associated deaths in Arizona, Pediatric influenza-associated deaths in Arizona, 2004-2012 (Poster is shared here as an 8.5 x11 document for easier viewing. All content is identical, though graphs and tables are formatted differently.)

More information

Influenza Weekly Surveillance Bulletin

Influenza Weekly Surveillance Bulletin Influenza ly Surveillance Bulletin Northern Ireland, (11-17 December ) Summary All indicators of influenza virus activity have increased. GP consultation rates for combined flu/ FLI increased from 28.1/,

More information

Respiratory tract infections. Krzysztof Buczkowski

Respiratory tract infections. Krzysztof Buczkowski Respiratory tract infections Krzysztof Buczkowski Etiology Viruses Rhinoviruses Adenoviruses Coronaviruses Influenza and Parainfluenza Viruses Respiratory Syncitial Viruses Enteroviruses Etiology Bacteria

More information

Surveillance of influenza in Northern Ireland: season

Surveillance of influenza in Northern Ireland: season Surveillance of influenza in Northern Ireland: 2017 2018 season Contents Introduction... 3 Enhanced influenza surveillance systems... 3 In-hours GP Practice surveillance... 3 GP Out-of-Hours surveillance...

More information

Nosocomial Pneumonia. <5 Days: Non-Multidrug-Resistant Bacteria

Nosocomial Pneumonia. <5 Days: Non-Multidrug-Resistant Bacteria Nosocomial Pneumonia Meredith Deutscher, MD Troy Schaffernocker, MD Ohio State University Burden of Hospital-Acquired Pneumonia Second most common nosocomial infection in the U.S. 5-10 episodes per 1000

More information

Epidemiology of Infectious Complications of H1N1 Influenza Virus Infection

Epidemiology of Infectious Complications of H1N1 Influenza Virus Infection Epidemiology of Infectious Complications of H1N1 Influenza Virus Infection Lyn Finelli, DrPH, MS Lead, Influenza Surveillance and Outbreak Response Epidemiology and Prevention Branch Influenza Division

More information

Volume 2 February 2011 LABORATORY UPDATE

Volume 2 February 2011 LABORATORY UPDATE Volume 2 February 2011 LABORATORY UPDATE www.dlolab.com Routine Testing New Tests Bacterial Pneumonia Panel... 3 Gastrointestinal Panel... 4 Infectious Disease Panel... 5 Respiratory Infections Panel...

More information

ZINEX. Composition Each tablet contains Cefuroxime (as axetil) 250 or 500 mg

ZINEX. Composition Each tablet contains Cefuroxime (as axetil) 250 or 500 mg ZINEX Composition Each tablet contains Cefuroxime (as axetil) 250 or 500 mg Tablets Action Cefuroxime axetil owes its bactericidal activity to the parent compound cefuroxime. Cefuroxime is a well-characterized

More information

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND A REPORT BY THE HEALTH PROTECTION SURVEILLANCE CENTRE IN COLLABORATION WITH THE IRISH MENINGITIS

More information

Influenza Weekly Surveillance Bulletin

Influenza Weekly Surveillance Bulletin Influenza ly Surveillance Bulletin Northern Ireland, 7- (19 November December 1) Summary Influenza activity in Northern Ireland remains at low levels. The GP combined flu/fli consultation rate increased

More information

Coordinate shipping to the Oregon State Public Health Lab through your local health department

Coordinate shipping to the Oregon State Public Health Lab through your local health department Interim Guidance for Clinicians on Testing, Evaluation, and Infection Prevention in the Management of Patients with Suspected Novel Respiratory Infections: Influenza A H7N9 and Middle East Respiratory

More information

Skin reactivity to autologous bacteria isolated from respiratory tract of patients with obstructive pulmonary disease

Skin reactivity to autologous bacteria isolated from respiratory tract of patients with obstructive pulmonary disease Skin reactivity to autologous bacteria 149 Original Article Skin reactivity to autologous bacteria isolated from respiratory tract of patients with obstructive pulmonary disease J. Halasa 1, M. Halasa

More information

INTRODUCTION TO UPPER RESPIRATORY TRACT DISEASES

INTRODUCTION TO UPPER RESPIRATORY TRACT DISEASES Upper Respiratory Tract Infections Return to Syllabus INTRODUCTION TO UPPER RESPIRATORY TRACT DISEASES General Goal: To know the major mechanisms of defense in the URT, the major mechanisms invaders use

More information

Client Services Manual

Client Services Manual Diagnostic Innovation Improving Health Client Services Manual [ Revised 12.21.18 ] Table of Contents About / Instructions Directory... 2 About Diatherix... 3 Specimen Preparation Instructions... 4 Packaging

More information

Tarrant County Influenza Surveillance Weekly Report CDC Week 17: April 22-28, 2012

Tarrant County Influenza Surveillance Weekly Report CDC Week 17: April 22-28, 2012 Tarrant County Public Health Division of Epidemiology and Health Information Tarrant County Influenza Surveillance Weekly Report CDC Week 17: April 22-28, 2012 Influenza Activity Code, County and State

More information

Oregon s Weekly Surveillance Report for Influenza and other Respiratory Viruses

Oregon s Weekly Surveillance Report for Influenza and other Respiratory Viruses FLU BITES Oregon s Weekly Surveillance Report for Influenza and other Respiratory Viruses Summary Published May 6, 2011 The level of influenza-like illness (ILI) detected by Oregon s outpatient ILI network

More information

CLIENT SERVICE MANUAL

CLIENT SERVICE MANUAL CLIENT SERVICE MANUAL [ V1.2 08.14.13] Linking Diagnostics to Therapeutics 2016 Diatherix Laboratories, LLC. All rights reserved. CSM -10.13.16 Linking Diagnostics to Therapeutics [ Revised 10.13.16 ]

More information

Live Poultry Markets in Bangkok Metropolitan, Thailand: A Survey of H5 & H7 Prevalence in Bird and Worker s vaccination and knowledge

Live Poultry Markets in Bangkok Metropolitan, Thailand: A Survey of H5 & H7 Prevalence in Bird and Worker s vaccination and knowledge Live Poultry Markets in Bangkok Metropolitan, Thailand: A Survey of H5 & H7 Prevalence in Bird and Worker s vaccination and knowledge Prabda Praphasiri, DrPH, PhD 29 August 2016 Thailand MOPH U.S. CDC

More information

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND A REPORT BY THE HEALTH PROTECTION SURVEILLANCE CENTRE IN COLLABORATION WITH THE IRISH MENINGITIS

More information

Tarrant County Influenza Surveillance Weekly Report CDC Week 11: Mar 10-16, 2019

Tarrant County Influenza Surveillance Weekly Report CDC Week 11: Mar 10-16, 2019 Tarrant County Public Health Division of Epidemiology and Health Information Tarrant County Influenza Surveillance Weekly Report 11: Mar 10-16, 2019 Influenza Activity Code: County and State Levels Tarrant

More information

Seasonal Influenza in Alberta 2010/2011 Summary Report

Seasonal Influenza in Alberta 2010/2011 Summary Report Seasonal Influenza in Alberta 21/211 Summary Report Government of Alberta October 211 ISSN 1927-4114, Surveillance and Assessment Branch Send inquiries to: Health.Surveillance@gov.ab.ca Executive Summary

More information

Surveillance of influenza in Northern Ireland

Surveillance of influenza in Northern Ireland Surveillance of influenza in Northern Ireland 2012 2013 Contents Summary... 1 Introduction... 2 Sources of data... 2 Sentinel GP surveillance... 2 Out-of-Hours Centres... 2 Virological surveillance...

More information

TABLE OF CONTENTS. About / Instructions. Test Catalog. Collection Procedures. Supplies / References. Directory...2 About Diatherix...

TABLE OF CONTENTS. About / Instructions. Test Catalog. Collection Procedures. Supplies / References. Directory...2 About Diatherix... TABLE OF CONTENTS About / Instructions Directory...2 About Diatherix...3 Specimen Preparation Instructions...4 Packaging and Shipping Instructions...5 Test Catalog Diatherix Panel List...6 Diatherix Panel

More information

CHMP List of questions

CHMP List of questions 28 June 2018 EMA/CHMP/346196/2018 To be addressed by the marketing authorisation holders for bacterial lysatescontaining medicinal products for respiratory conditions Referral under Article 31 of Directive

More information

CLIENT SERVICE MANUAL

CLIENT SERVICE MANUAL CLIENT SERVICE MANUAL [ V1.2 08.14.13] Linking Diagnostics to Therapeutics [ Revised 05.25.16 ] TABLE OF CONTENTS About / Instructions Directory...2 About Diatherix...3 Specimen Preparation Instructions...4

More information

Potential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections.

Potential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections. In the name of God Principles of post Tx infections 1: Potential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections. Infection processes can progress

More information

Upper...and Lower Respiratory Tract Infections

Upper...and Lower Respiratory Tract Infections Upper...and Lower Respiratory Tract Infections Robin Jump, MD, PhD Cleveland Geriatric Research Education and Clinical Center (GRECC) Louis Stokes Cleveland VA Medical Center Case Western Reserve University

More information

Likelihood that an unsubtypeable Influenza A result. in the Luminex xtag Respiratory Virus Panel. is indicative of novel A/H1N1 (swine-like) influenza

Likelihood that an unsubtypeable Influenza A result. in the Luminex xtag Respiratory Virus Panel. is indicative of novel A/H1N1 (swine-like) influenza JCM Accepts, published online ahead of print on 3 June 2009 J. Clin. Microbiol. doi:10.1128/jcm.01027-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance Flu Watch MMWR Week 3: January 14 to January 2, 218 All data are provisional and subject to change as more reports are received. Geographic Spread South Carolina reported widespread activity this week.

More information

Treatment of febrile neutropenia in patients with neoplasia

Treatment of febrile neutropenia in patients with neoplasia Treatment of febrile neutropenia in patients with neoplasia George Samonis MD, PhD Medical Oncologist Infectious Diseases Specialist Professor of Medicine The University of Crete, Heraklion,, Crete, Greece

More information

Management of URTI s in Children

Management of URTI s in Children Management of URTI s in Children Robin J Green PhD Antibiotics - Dilemmas for General Practitioners Antibiotic overuse = Resistance Delay in antibiotic use = Mortality Patient expectation Employer expectation

More information

Tarrant County Influenza Surveillance Weekly Report CDC Week 39: Sept 23-29, 2018

Tarrant County Influenza Surveillance Weekly Report CDC Week 39: Sept 23-29, 2018 Tarrant County Public Health Division of Epidemiology and Health Information Tarrant County Influenza Surveillance Weekly Report 39: Sept 23-29, 2018 Influenza Activity Code: County and State Levels Tarrant

More information

Influenza Activity Level 3 ILI 5 Activity

Influenza Activity Level 3 ILI 5 Activity Respiratory Virus Surveillance Report 1 New Jersey Department of Health Communicable Disease Service Week ending December 3, 217 (MMWR week 52 2 ) Week 4 Week 45 Week 5 Week 3 Week 8 Week 13 Week 18 Week

More information

Torres, Brian Carlmichael L., Ma. Luisa G. Daroy, Juan s. Lopez, Vanessa Oh, Marie Joan Loy, Prospero ma. Tuaño, and Ronald R. Matias Research and

Torres, Brian Carlmichael L., Ma. Luisa G. Daroy, Juan s. Lopez, Vanessa Oh, Marie Joan Loy, Prospero ma. Tuaño, and Ronald R. Matias Research and Torres, Brian Carlmichael L., Ma. Luisa G. Daroy, Juan s. Lopez, Vanessa Oh, Marie Joan Loy, Prospero ma. Tuaño, and Ronald R. Matias Research and Biotechnology Division and International Eye Institute

More information

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory CEFTUM TABLETS. Cefuroxime Axetil Tablets IP 125/250/500mg

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory CEFTUM TABLETS. Cefuroxime Axetil Tablets IP 125/250/500mg For the use only of Registered Medical Practitioners or a Hospital or a Laboratory CEFTUM TABLETS Cefuroxime Axetil Tablets IP 125/250/500mg QUALITATIVE AND QUANTITATIVE COMPOSITION CEFTUM TABLETS 125

More information

The Bacteriology of Bronchiectasis in Australian Indigenous children

The Bacteriology of Bronchiectasis in Australian Indigenous children The Bacteriology of Bronchiectasis in Australian Indigenous children Kim Hare, Amanda Leach, Peter Morris, Heidi Smith-Vaughan, Anne Chang Presentation outline What is bronchiectasis? Our research at Menzies

More information

27/11/2012. Parainfuenza 1, 2 3 Rhinovirus Coronavirus Adenovirus Respiratory syncytial virus (RSV) Chlamydophila pneumoniae Mycoplasma pneumonite

27/11/2012. Parainfuenza 1, 2 3 Rhinovirus Coronavirus Adenovirus Respiratory syncytial virus (RSV) Chlamydophila pneumoniae Mycoplasma pneumonite 8 «Evidence-based Medicine-» 27/11/2012,,,, : :,,,,,,,, (30%-50%) () (5%-10%) (40%-50%) 20% Infuenza A B Parainfuenza 1, 2 3 Rhinovirus Coronavirus Adenovirus Respiratory syncytial virus (RSV) Chlamydophila

More information

ARIZONA INFLUENZA SUMMARY Week 1 (1/4/2015 1/10/2015)

ARIZONA INFLUENZA SUMMARY Week 1 (1/4/2015 1/10/2015) ARIZONA INFLUENZA SUMMARY Week 1 (1/4/2015 1/10/2015) 2014-2015 Season (9/28/2014 10/3/2015) Synopsis: Influenza activity is increasing in Arizona. Arizona reported Widespread activity for week 1. Influenza

More information

HYPOCHLOROUS ACID (HOCl) Our Body's immune system protector in a BOTTLE

HYPOCHLOROUS ACID (HOCl) Our Body's immune system protector in a BOTTLE AQUAOX IS A REVOLUTIONARY DISINFECTION SOLUTION WHICH ACTIVE INGREDIENT HOCL IS NON HAZARDOUS, HAS NO FRAGRANCE, AND IS SAFE ON ALL SURFACES (AND ON SKIN.) HYPOCHLOROUS ACID (HOCl) Our Body's immune system

More information

Client Services M anual

Client Services M anual Diagnostic Innovation Improving Health Client Services M anual [ Revised 09.27.18 ] Table of Contents About / Instructions Directory...2 About Diatherix...3 Specimen Preparation Instructions...4 Packaging

More information

Influenza Activity Level 3 ILI 5 Activity

Influenza Activity Level 3 ILI 5 Activity Respiratory Virus Surveillance Report 1 New Jersey Department of Health Communicable Disease Service Week ending February 1, 218 (MMWR week 6 2 ) Week 4 Week 45 Week 5 Week 3 Week 8 Week 13 Week 18 Week

More information

The importance of considering BACTERIAL LOAD in OTITIS MEDIA research

The importance of considering BACTERIAL LOAD in OTITIS MEDIA research The importance of considering BACTERIAL LOAD in OTITIS MEDIA research Heidi Smith-Vaughan, Robyn Marsh, Michael Binks, Mirjam Kaestli, Peter S Morris, Amanda J Leach OM in Indigenous children OM is endemic

More information

ANWICU knowledge

ANWICU knowledge ANWICU knowledge www.anwicu.org.uk This presenta=on is provided by ANWICU We are a collabora=ve associa=on of ICUs in the North West of England. Permission to provide this presenta=on has been granted

More information

Lower respiratory tract infections

Lower respiratory tract infections 12 Community-Acquired : Bacteriological Profile and Microbiological Investigations Ravi Kumar 1, Canna Ghia 2, Shaumil Waghela 3, Harish Thanusubramanian 4, Gautam Rambhad 5 Introduction Lower respiratory

More information

Report on. Thailand Gender-Disaggregated Statistics 2008

Report on. Thailand Gender-Disaggregated Statistics 2008 Report on Thailand Gender-Disaggregated Statistics 2008 Office of WomenÊs Affairs and Family Development Ministry of Social Development and Human Security in collaboration with United Nations Development

More information

VOLOXAL. Composition each tablet contains levofloxacin 500 & 750 mg

VOLOXAL. Composition each tablet contains levofloxacin 500 & 750 mg VOLOXAL Composition each tablet contains levofloxacin 500 & 750 mg Tablets Action Bactericidal; as a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA-gyrase complex and topoisomerase IV

More information

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND A REPORT BY THE HEALTH PROTECTION SURVEILLANCE CENTRE IN COLLABORATION WITH THE IRISH MENINGITIS

More information

Texas Influenza Summary Report, Season (September 28, 2008 April 11, 2009)

Texas Influenza Summary Report, Season (September 28, 2008 April 11, 2009) Texas Influenza Summary Report, 2008 2009 Season (September 28, 2008 April 11, 2009) Background Influenza and influenza-like illnesses (ILI) were last reportable by law in any county in Texas in 1993 (1).

More information

Tarrant County Influenza Surveillance Weekly Report CDC Week 17: April 22-28, 2018

Tarrant County Influenza Surveillance Weekly Report CDC Week 17: April 22-28, 2018 Tarrant County Public Health Division of Epidemiology and Health Information Tarrant County Influenza Surveillance Weekly Report 17: April 22-28, 2018 Influenza Activity Code: County and State Levels Tarrant

More information

Pneumonia (PNEU) and Ventilator-Associated Pneumonia (VAP) Prevention. Basics of Infection Prevention 2-Day Mini-Course 2016

Pneumonia (PNEU) and Ventilator-Associated Pneumonia (VAP) Prevention. Basics of Infection Prevention 2-Day Mini-Course 2016 Pneumonia (PNEU) and Ventilator-Associated Pneumonia (VAP) Prevention Basics of Infection Prevention 2-Day Mini-Course 2016 Objectives Differentiate long term care categories of respiratory infections

More information

PNEUMONIA IN CHILDREN. IAP UG Teaching slides

PNEUMONIA IN CHILDREN. IAP UG Teaching slides PNEUMONIA IN CHILDREN 1 INTRODUCTION 156 million new episodes / yr. worldwide 151 million episodes developing world 95% in developing countries 19% of all deaths in children

More information

Laboratory Evidence of Human Viral and Selected Non-viral Infections in Canada

Laboratory Evidence of Human Viral and Selected Non-viral Infections in Canada Canada Communicable Disease Report ISSN 1188-4169 Date of publication: October 1998 Volume 24S7 Supplement Laboratory Evidence of Human Viral and Selected Non-viral Infections in Canada 1989 to 1996 Our

More information

Downloaded from:

Downloaded from: Muller-Pebody, B; Crowcroft, NS; Zambon, MC; Edmunds, WJ (2006) Modelling hospital admissions for lower respiratory tract infections in the elderly in England. Epidemiology and infection, 134 (6). pp.

More information

RESPIRATORY TRACT INFECTIONS. CLS 212: Medical Microbiology

RESPIRATORY TRACT INFECTIONS. CLS 212: Medical Microbiology RESPIRATORY TRACT INFECTIONS CLS 212: Medical Microbiology Anatomy of the Respiratory System Respiratory Infections Respiratory tract can be divided into: Upper Respiratory Tract (URT): Sinuses Nasopharynx,.

More information

LABORATORY TRENDS. Laboratory News PUBLIC HEALTH MICROBIOLOGY & REFERENCE LABORATORY. Vancouver, BC. December 21, 2011.

LABORATORY TRENDS. Laboratory News PUBLIC HEALTH MICROBIOLOGY & REFERENCE LABORATORY. Vancouver, BC. December 21, 2011. & REFERENCE Laboratory News Genome BC Water Grant Earlier in 11, PHMRL leaders Drs. Patrick Tang and Judy Isaac-Renton, along with Drs. Natalie Prystajecky and Jennifer Gardy and supported by many colleagues

More information